Login
← Go Back
Senores Pharmaceuticals
SENORES · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 30, 2024
Stock Price vs Company Growth
1d
3.7%
1w
2.8%
1m
18.7%
3m
44.1%
6m
43.1%
1y
122.1%
all
63.4%
đŸ¤” How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,114 3.7%
708
1,193
Company Overview
Sales
650 Cr
Growth: 45.0%
Profit after Tax
115 Cr
Growth: 13.6%
Small Cap
5,129 Cr
P/E: 42.2x
Industry P/E: 31.1x
Fundamentals
Sales (Cr) ₹ 650
Growth 45.0%
EBITDA 28.5%
P/S 7.9x
Dividend 0.0%
P/E 42.2x
Book Value ₹ 203
PEG Ratio 0.9x
ROE 13.4%
P/B 5.5x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
Senores Pharmaceuticals Limited was originally incorporated as ‘Senores Pharmaceuticals Private Limited’ under the Companies Act, 2013 through certificate of incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
Belongs to (4 Indices)
Investors (13)
jeshika....
sanjay.s...
ashokbha...
Followers (1)
varsha96